Related references
Note: Only part of the references are listed.Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
Giuseppe Ando et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulationd-And With Which Anticoagulant?
Robert G. Hart et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
Xiaoli Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease
Arman Qamar et al.
CIRCULATION (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
Kevin E. Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey
Tatjana S. Potpara et al.
EUROPACE (2015)
Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation A Meta-Analysis of Observational Studies
Gang Liu et al.
MEDICINE (2015)
Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation
Rui Providencia et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
Mitesh Shah et al.
CIRCULATION (2014)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
CIRCULATION (2014)
Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study
Minako Wakasugi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2014)
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study
Anders Nissen Bonde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Khai P. Ng et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Warfarin for Prevention of Thrombosis Among Long-Term Care Residents with Atrial Fibrillation: Evidence of Continuing Low Use Despite Consideration of Stroke and Bleeding Risk
Gregory Reardon et al.
DRUGS & AGING (2013)
Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'
Konrad M. Andrassy
KIDNEY INTERNATIONAL (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Antithrombotic Therapy in Patients With Chronic Kidney Disease
Davide Capodanno et al.
CIRCULATION (2012)
Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate
Kunihiro Matsushita et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
Jonas Bjerring Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
John W. Eikelboom et al.
CIRCULATION (2011)
Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Usman Baber et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2011)
Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation
Wolfgang C. Winkelmayer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
Robert G. Hart et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
Keith A. A. Fox et al.
EUROPEAN HEART JOURNAL (2011)
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs
J. Kooiman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog et al.
KIDNEY INTERNATIONAL (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
Wanwarat Ananthapanyasut et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy
Volker Wizemann et al.
KIDNEY INTERNATIONAL (2010)
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
Hiroshi Watanabe et al.
AMERICAN HEART JOURNAL (2009)
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Alan S. Go et al.
CIRCULATION (2009)
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Holger Reinecke et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
Kevin E. Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Relation of Atrial Fibrillation to Glomerular Filtration Rate
Yasuyuki Iguchi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Share Paper
